We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 10 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 21 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 23. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2026. 04. 22. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2026. 04. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 04. 22. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 04. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 04. 07. | Jefferies | — | Maintain | Buy → Buy | — | Jefferies: Buy |
| 2026. 01. 21. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 01. 21. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2026. 01. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 12. 13. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 27. | CICC | — | Initiate coverage | — → Outperform | — | CICC: Outperform |
| 2025. 10. 17. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 17. | BMO Capital | — | Maintain | Outperform → Outperform | — | BMO Capital: Outperform |
| 2025. 10. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 03. | BMO Capital | — | Initiate coverage | — → Outperform | — | BMO Capital: Outperform |
| 2025. 07. 19. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 07. 18. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 07. 15. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 07. 11. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 07. 08. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 06. 09. | Citigroup | — | Downgrade | Buy → Neutral | — | Citigroup: Buy → Neutral |
| 2025. 05. 16. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 05. 01. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 04. 22. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 04. 16. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 04. 16. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 04. 16. | B of A Securities | — | Maintain | Buy → Buy | — | B of A Securities: Buy |
| 2025. 04. 09. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 04. 08. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 04. 07. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 04. 03. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 01. 28. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2025. 01. 23. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 01. 22. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 01. 22. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 01. 14. | Keefe, Bruyette & Woods | — | Maintain | Market Perform → Market Perform | — | Keefe, Bruyette & Woods: Market Perform |
| 2025. 01. 13. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 01. 11. | Citigroup | — | Maintain | Buy → Buy | — | Citigroup: Buy |
| 2025. 01. 07. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2025. 01. 06. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |